Prothena Corporation plc
PRTA
$11.07
$0.726.96%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 148.97% | -96.65% | 5,556.00% | 571.84% | -98.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 148.97% | -96.65% | 5,556.00% | 571.84% | -98.86% |
| Cost of Revenue | -42.95% | -29.55% | -20.75% | -18.93% | -12.42% |
| Gross Profit | 46.69% | -148.45% | 25.10% | 21.97% | -284.59% |
| SG&A Expenses | -21.01% | -1.35% | 0.77% | -0.54% | 0.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.50% | -23.37% | -16.14% | -14.98% | -9.49% |
| Operating Income | 40.22% | -189.09% | 19.56% | 17.34% | -745.26% |
| Income Before Tax | 38.31% | -224.86% | 17.55% | 15.74% | -418.02% |
| Income Tax Expenses | 55.57% | 2,297.25% | 46.48% | 50.83% | 72.99% |
| Earnings from Continuing Operations | 38.07% | -288.03% | 16.67% | 14.11% | -369.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.07% | -288.03% | 16.67% | 14.11% | -369.32% |
| EBIT | 40.22% | -189.09% | 19.56% | 17.34% | -745.26% |
| EBITDA | 40.36% | -188.35% | 19.62% | 17.34% | -729.09% |
| EPS Basic | 38.12% | -287.82% | 16.85% | 14.35% | -368.19% |
| Normalized Basic EPS | 39.16% | -174.49% | 17.73% | 15.98% | -416.62% |
| EPS Diluted | 38.12% | -291.80% | 16.85% | 14.35% | -388.66% |
| Normalized Diluted EPS | 39.16% | -176.26% | 17.73% | 15.98% | -443.02% |
| Average Basic Shares Outstanding | 0.07% | 0.11% | 0.21% | 0.27% | 0.43% |
| Average Diluted Shares Outstanding | 0.07% | -2.21% | 0.21% | 0.27% | -7.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |